Global Antihelminthics Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Antihelminthics market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Antihelminthics market."
Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host.

The global Antihelminthics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antihelminthics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antihelminthics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Abbott
    Novartis
    ZEISS International
    Johnson & Johnson
    Sanofi
    Merck & Co.
    GlaxoSmithKline
    Astellas Pharma
    Bayer
    Mentis Pharma
    Pfizer
    Sanofi
    ALLERGAN
    AstraZeneca

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Benzimidazoles
    Abamectin
    Salicylanilides
    Praziquantel
    Other

Segment by Application
    Schistosomiasis
    Fasciolasis
    Filariasis
    Angiostrongylosis
    Ascariasis
    Giardiasis
    Other